2nd Quarter - Amendment

PLASTICS INDUSTRY ASSOCIATION, INC. for PLASTICS INDUSTRY ASSOCIATION, INC.

Firm
Client
Income
—
Expenses
$70,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Energy/Nuclear ENG

Energy Costs & Access, including Outer Continental Shelf (no specific bill) New Alternative Transportation to Give Americans Solutions Act of 2011 (H.R. 1380/S. 1863) Hydraulic Fracturing (no specific bill)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Bills named: S. 1863 (112th), H.R. 1380 (112th)

Taxation/Internal Revenue Code TAX

Research & Experimentation tax credit extension (H.R. 942) Last-in/First-out (LIFO) accounting method preservation (no specific bill) R&D Tax Credit (H.R. 1577) Pending Expiration of 2001/2003 Tax Cuts

LobbyistCovered position, as disclosed
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 942 (112th), H.R. 1577 (112th)

Trade (domestic/foreign) TRD

The Miscellaneous Tariff Bill (MTB) (no specific bills) Russia PNTR (no specific bills)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
MICHAEL TAYLOR —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Food Industry (safety, labeling, etc.) FOO

F.Y. 2012 House and Senate Appropriations legislation -- FDA funding

LobbyistCovered position, as disclosed
JONATHAN KURRLE —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA)

Environment/Superfund ENV

Proposed Toxic Substances Control Act revisions (S.847) Reimposition of Superfund tax (no specific bill) Congressional Oversight of EPA (H.R. 2250/S. 1392) Energy Tax Prevention Act of 2011 (H.R. 910)

LobbyistCovered position, as disclosed
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Bills named: S. 1392 (112th), H.R. 910 (112th), S. 847 (112th), H.R. 2250 (112th)

Consumer Issues/Safety/Products CSP

Enhancing CPSC Authority and Discretion Act of 2011 (H.R. 1939)

LobbyistCovered position, as disclosed
JONATHAN KURRLE —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 1939 (112th)

Labor Issues/Antitrust/Workplace LBR

OSHA proposed regulation on combustible dust (no specific bill) OSHA proposed regulation on workplace noise (no specific bill) National Labor Relations Board activities (no specific bill) Protecting Jobs From Government Interference Act (H.R. 2587)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
PATRICIA DAVITT LONG New —
SUZANNE MORGAN —

Contacted: Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2587 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.